TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+6.62%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$661M
AUM Growth
+$661M
(+3.8%)
Cap. Flow
-$1.94M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
41.26%
Holding
75
New
1
Increased
26
Reduced
31
Closed
1
Top Buys
| 1 |
Henry Schein
HSIC
|
$8.17M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$4.66M |
| 3 |
Starbucks
SBUX
|
$2.15M |
| 4 |
United Parcel Service
UPS
|
$773K |
| 5 |
Ross Stores
ROST
|
$704K |
Top Sells
| 1 |
Schlumberger
SLB
|
$8.01M |
| 2 |
GE Aerospace
GE
|
$3.85M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
$2.62M |
| 4 |
Occidental Petroleum
OXY
|
$1.69M |
| 5 |
Brown-Forman Class B
BF.B
|
$1.68M |
Sector Composition
| 1 | Healthcare | 43.37% |
| 2 | Technology | 13.29% |
| 3 | Industrials | 9.64% |
| 4 | Consumer Staples | 6.48% |
| 5 | Consumer Discretionary | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cognex
CGNX
$7.38B
| $42.4M | 6.41% |
384,585
-14,995
| -4% | -$1.65M |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $32.5M | 4.91% |
353,766
+1,030
| +0.3% | +$94.5K |
|
3
Analog Devices
ADI
$124B
| $28.4M | 4.3% |
329,856
+1,541
| +0.5% | +$133K |
|
4
Neogen
NEOG
$1.25B
| $26.7M | 4.03% |
344,409
-235
| -0.1% | -$18.2K |
|
5
Johnson & Johnson
JNJ
$427B
| $25.9M | 3.92% |
199,183
+560
| +0.3% | +$72.8K |
|
|
RTN
6
DELISTED
Raytheon Company
RTN
| $25.1M | 3.8% |
134,667
-555
| -0.4% | -$104K |
|
7
Idexx Laboratories
IDXX
$51.8B
| $24.1M | 3.64% |
154,835
+835
| +0.5% | +$130K |
|
8
Biogen
BIIB
$19.4B
| $23.4M | 3.54% |
74,804
+100
| +0.1% | +$31.3K |
|
9
Honeywell
HON
$139B
| $22.4M | 3.38% |
157,932
-915
| -0.6% | -$130K |
|
10
Mastercard
MA
$538B
| $22M | 3.32% |
155,700
+820
| +0.5% | +$116K |
|
|
11
Brown-Forman Class B
BF.B
$14.2B
| $21M | 3.17% |
386,396
-30,953
| -7% | -$1.68M |
|
12
Danaher
DHR
$147B
| $20.9M | 3.16% |
243,960
+1,525
| +0.6% | +$131K |
|
13
Novo Nordisk
NVO
$251B
| $19.9M | 3.01% |
413,965
+4,045
| +1% | +$195K |
|
14
Insulet
PODD
$23.9B
| $16.8M | 2.54% |
305,260
+585
| +0.2% | +$32.2K |
|
|
15
Henry Schein
HSIC
$8.44B
| $16.3M | 2.47% |
198,878
+99,634
| +100% | +$8.17M |
|
16
Inogen
INGN
$216M
| $15.8M | 2.39% |
165,955
-185
| -0.1% | -$17.6K |
|
|
17
Starbucks
SBUX
$100B
| $14.9M | 2.26% |
277,915
+40,065
| +17% | +$2.15M |
|
18
Amgen
AMGN
$155B
| $14.9M | 2.25% |
79,784
-1,950
| -2% | -$364K |
|
19
Dentsply Sirona
XRAY
$2.85B
| $14.9M | 2.25% |
248,398
+5,187
| +2% | +$310K |
|
|
20
Ross Stores
ROST
$48.1B
| $13.8M | 2.09% |
214,180
+10,900
| +5% | +$704K |
|
|
ABMD
21
DELISTED
Abiomed Inc
ABMD
| $13.7M | 2.07% |
81,155
+125
| +0.2% | +$21.1K |
|
22
DexCom
DXCM
$29.5B
| $13.2M | 2% |
270,595
+2,900
| +1% | +$142K |
|
23
Mettler-Toledo International
MTD
$26.8B
| $13M | 1.96% |
20,685
-475
| -2% | -$297K |
|
24
AbbVie
ABBV
$372B
| $11.4M | 1.73% |
128,700
+400
| +0.3% | +$35.5K |
|
25
State Street
STT
$32.6B
| $10.3M | 1.55% |
107,624
-550
| -0.5% | -$52.5K |
|